Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicin.
Seymour LW, Ferry DR, Anderson D, Hesslewood S, Julyan PJ, Poyner R, Doran J, Young AM, Burtles S, Kerr DJ; Cancer Research Campaign Phase I/II Clinical Trials committee.
Seymour LW, et al. Among authors: julyan pj.
J Clin Oncol. 2002 Mar 15;20(6):1668-76. doi: 10.1200/JCO.2002.20.6.1668.
J Clin Oncol. 2002.
PMID: 11896118
Clinical Trial.